A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Clinical trial NCT02215499 · COMPLETED

Trial details

NCT number: NCT02215499
Sponsor: Concert Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Narcolepsy, Excessive Daytime Sleepiness

Start date: 2014-07-01
Primary completion: 2014-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.